Cell Therapy for Lupus: Naiesha’s Story
In 2025, CHOP launched a clinical trial using CAR T to treat a young woman with systemic lupus erythematosus. The therapy transformed her life.
Read stories about patients who have been cared for by the Blood and Marrow Transplant Program.
In 2025, CHOP launched a clinical trial using CAR T to treat a young woman with systemic lupus erythematosus. The therapy transformed her life.
After years of care at CHOP, including groundbreaking gene therapy delivered as part of a clinical trial, 11-year-old Lily continues to not only grow and gain but thrive.
When she was 16, Regina came to CHOP for a procedure that restored her health and put her on the path to becoming a pediatric primary care doctor.
Conor would not have survived the leukemia that led to months-long stays in in CHOP’s ICU if not for the teamwork of the doctors who collaborated on his care.
An FDA-approved gene therapy is giving people with sickle cell disease a future they didn’t think they’d have.
Genetic sequencing revealed that Rafi had an extremely rare, often fatal disease — and the discovery was amazingly made before he had serious symptoms.
For years, sickle cell disease caused frequent pain crises and hospitalizations for Asher. A curative therapy has eliminated those harrowing experiences.
Sickle cell disease brings constant fear of life-threatening complications. A successful bone marrow transplant ended those fears for Dallas and her family.
18-month-old Josie received a stem cell transplant to stop a rare and devastating genetic condition in its tracks.
Diagnosed before his first birthday with a rare disease that causes ongoing damage to cells and organs, Ethan quickly received the only treatment that prevents further disease.